Extrovis` Sugammadex Receives Approval in Europe
16 Jun 2023 //
EMA
Extrovis` Lacosamide Adroiq (lacosamide) Receives Approval in Europe
05 Jun 2023 //
EMA
Megasoft completed the acquisition of 40% stake in Extrovis AG.
19 Jan 2023 //
MARKET SCREENER
Megasoft Limited agreed to acquire 40% stake in EXTROVIS AG for $16 million.
15 May 2022 //
MARKETSCREENER